WallStreetZenWallStreetZen

NASDAQ: SERA
Sera Prognostics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their SERA stock forecasts and price targets.

Forecast return on equity

Is SERA forecast to generate an efficient return?

Company
-33.22%
Industry
10.66%
Market
-19.91%
SERA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SERA forecast to generate an efficient return on assets?

Company
-26.21%
Industry
10.71%
SERA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SERA earnings per share forecast

What is SERA's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.73
Avg 2 year Forecast
-$0.77

SERA revenue forecast

What is SERA's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$300.0k+177.78%
Avg 2 year Forecast
$1.5M+1,242.59%
SERA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SERA revenue growth forecast

How is SERA forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
177.78%
Industry
2.74%
Market
120.74%
SERA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SERA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SERA vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
SERA$2.38N/AN/A
PRE$7.29N/AN/A
FONR$15.22N/AN/A
BNR$9.86N/AN/A
VNRX$0.68$3.50+413.95%Strong Buy
View Top Diagnostic & Research Stocks

Sera Prognostics Stock Forecast FAQ

What is SERA's earnings growth forecast for 2025-2026?

(NASDAQ: SERA) Sera Prognostics's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 37.34%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 55.46%.

Sera Prognostics's earnings in 2025 is -$32,731,000.On average, 1 Wall Street analyst forecast SERA's earnings for 2025 to be -$27,785,164, with the lowest SERA earnings forecast at -$27,785,164, and the highest SERA earnings forecast at -$27,785,164.

In 2026, SERA is forecast to generate -$29,307,638 in earnings, with the lowest earnings forecast at -$29,307,638 and the highest earnings forecast at -$29,307,638.

If you're new to stock investing, here's how to buy Sera Prognostics stock.

What is SERA's revenue growth forecast for 2025-2026?

(NASDAQ: SERA) Sera Prognostics's forecast annual revenue growth rate of 177.78% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 2.74%, and it is also forecast to beat the US market's average forecast revenue growth rate of 120.74%.

Sera Prognostics's revenue in 2025 is $108,000.On average, 1 Wall Street analysts forecast SERA's revenue for 2025 to be $11,418,560, with the lowest SERA revenue forecast at $11,418,560, and the highest SERA revenue forecast at $11,418,560.

In 2026, SERA is forecast to generate $55,189,709 in revenue, with the lowest revenue forecast at $53,286,615 and the highest revenue forecast at $57,092,802.

What is SERA's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: SERA) forecast ROA is -26.21%, which is lower than the forecast US Diagnostics & Research industry average of 10.71%.

What is SERA's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: SERA) Sera Prognostics's current Earnings Per Share (EPS) is -$0.85. On average, analysts forecast that SERA's EPS will be -$0.73 for 2025, with the lowest EPS forecast at -$0.73, and the highest EPS forecast at -$0.73. In 2026, SERA's EPS is forecast to hit -$0.77 (min: -$0.77, max: -$0.77).

What is SERA's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: SERA) forecast ROE is -33.22%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.